Ming-Hong Tai Selected Research

hepatoma-derived growth factor

12/2020	Hepatoma-derived growth factor participates in concanavalin A-induced hepatitis.
11/2019	Novel HDGF/HIF-1α/VEGF axis in oral cancer impacts disease prognosis.
1/2019	Hepatoma-derived growth factor participates in Helicobacter Pylori-induced neutrophils recruitment, gastritis and gastric carcinogenesis.
11/2018	Helicobacter pylori Infection-Induced Hepatoma-Derived Growth Factor Regulates the Differentiation of Human Mesenchymal Stem Cells to Myofibroblast-Like Cells.
10/2018	Domain swapping and SMYD1 interactions with the PWWP domain of human hepatoma-derived growth factor.
6/2015	Hepatoma-derived growth factor/nucleolin axis as a novel oncogenic pathway in liver carcinogenesis.
6/2013	Downregulation of hepatoma-derived growth factor contributes to retarded lung metastasis via inhibition of epithelial-mesenchymal transition by systemic POMC gene delivery in melanoma.
1/2013	Up-regulation of hepatoma-derived growth factor facilitates tumor progression in malignant melanoma [corrected].
10/2012	Hepatoma-derived growth factor regulates breast cancer cell invasion by modulating epithelial--mesenchymal transition.
8/2012	Hepatoma-derived growth factor stimulates podosome rosettes formation in NIH/3T3 cells through the activation of phosphatidylinositol 3-kinase/Akt pathway.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ming-Hong Tai Research Topics

Disease

37	Neoplasms (Cancer) 01/2022 - 04/2003
11	Hepatocellular Carcinoma (Hepatoma) 07/2021 - 12/2007
11	Melanoma (Melanoma, Malignant) 01/2021 - 02/2006
9	Infections 01/2021 - 01/2004
7	Inflammation (Inflammations) 10/2021 - 02/2006
7	Carcinogenesis 12/2020 - 02/2006
6	Choroidal Neovascularization 09/2018 - 12/2005
6	Neoplasm Metastasis (Metastasis) 08/2017 - 02/2006
5	Fibrosis (Cirrhosis) 12/2020 - 07/2005
5	Neuroblastoma 08/2013 - 05/2005
4	Liver Cirrhosis (Hepatic Cirrhosis) 01/2018 - 07/2005
4	Hypoxia (Hypoxemia) 01/2018 - 07/2009
3	Carcinoma (Carcinomatosis) 01/2022 - 08/2017
3	Liver Neoplasms (Liver Cancer) 04/2021 - 03/2014
3	Lymphatic Metastasis 01/2019 - 09/2016
3	Breast Neoplasms (Breast Cancer) 09/2016 - 04/2009
3	Neuralgia (Stump Neuralgia) 03/2015 - 06/2011
3	Angiostrongyliasis 03/2014 - 06/2009
3	Meningitis 03/2014 - 06/2009
2	Rheumatoid Arthritis 10/2021 - 06/2008
2	Atherosclerosis 06/2021 - 02/2015
2	Syphilis 01/2021 - 05/2011
2	Burns 10/2020 - 01/2020
2	Mouth Neoplasms (Oral Cancer) 11/2019 - 07/2012
2	Ischemia 01/2018 - 02/2005
2	Experimental Liver Neoplasms 01/2018 - 03/2014
2	Prostatic Neoplasms (Prostate Cancer) 12/2016 - 05/2009
2	Hyperalgesia 03/2015 - 01/2014
2	Spinal Cord Injuries (Spinal Cord Injury) 01/2014 - 10/2003
2	Peripheral Nerve Injuries 01/2014 - 06/2011
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2008 - 09/2007
2	Bradycardia 05/2007 - 02/2005
2	Hypotension (Low Blood Pressure) 05/2007 - 02/2005

Drug/Important Bio-Agent (IBA)

15	hepatoma-derived growth factorIBA 12/2020 - 09/2007
12	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 10/2021 - 02/2006
9	Proteins (Proteins, Gene)FDA Link 07/2021 - 05/2005
6	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2014 - 10/2003
5	Melanocyte-Stimulating Hormones (MSH)IBA 10/2021 - 01/2012
5	Pharmaceutical PreparationsIBA 07/2021 - 03/2014
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2019 - 10/2008
5	EnzymesIBA 01/2019 - 05/2009
5	Peptides (Polypeptides)IBA 09/2018 - 04/2010
5	Nerve Growth Factors (Neurotrophins)IBA 06/2011 - 02/2005
5	Proliferating Cell Nuclear Antigen (PCNA)IBA 02/2009 - 09/2007
4	Therapeutic UsesIBA 10/2021 - 04/2012
4	CalreticulinIBA 09/2018 - 04/2010
4	Angiogenesis InhibitorsIBA 09/2014 - 01/2005
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2013 - 09/2007
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2012
3	CateninsIBA 01/2022 - 01/2012
3	Cisplatin (Platino)FDA LinkGeneric 10/2020 - 05/2013
3	Transforming Growth Factor beta (TGF-beta)IBA 01/2020 - 07/2009
3	Cadherins (E-Cadherin)IBA 01/2019 - 10/2012
3	Matrix Metalloproteinases (MMPs)IBA 01/2019 - 07/2005
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 06/2015 - 04/2003
3	ImmunosorbentsIBA 02/2014 - 05/2009
3	CytokinesIBA 01/2014 - 08/2005
3	Toll-Like Receptor 3IBA 08/2013 - 08/2011
3	NeuropeptidesIBA 03/2011 - 02/2006
3	Ophthalmic Solutions (Eye Drops)IBA 04/2010 - 01/2005
3	vasostatinIBA 09/2009 - 01/2005
2	MicroRNAs (MicroRNA)IBA 01/2022 - 08/2017
2	Hormones (Hormone)IBA 10/2021 - 06/2013
2	Dinoprostone (PGE2)FDA Link 07/2021 - 01/2020
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2021 - 02/2006
2	Biological ProductsIBA 04/2021 - 03/2016
2	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2021 - 05/2014
2	Glucose (Dextrose)FDA LinkGeneric 10/2020 - 06/2014
2	Type 1 Melanocortin ReceptorIBA 01/2020 - 01/2012
2	Caspase 3 (Caspase-3)IBA 01/2020 - 05/2014
2	CaspasesIBA 01/2020 - 06/2011
2	heteroneminIBA 01/2019 - 12/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 05/2014
2	LigandsIBA 01/2019 - 01/2018
2	AntioxidantsIBA 01/2019 - 05/2014
2	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2018 - 01/2010
2	Celecoxib (Celebrex)FDA Link 01/2018 - 03/2014
2	Oxygen (Dioxygen)IBA 01/2018 - 04/2010
2	Epirubicin (Ellence)FDA LinkGeneric 01/2018 - 07/2010
2	Tight Junction ProteinsIBA 08/2017 - 06/2009
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 12/2016 - 06/2009
2	TensinsIBA 04/2016 - 03/2015
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 04/2016 - 03/2015
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 06/2015 - 06/2008
2	Adrenocorticotropic Hormone (ACTH)FDA Link 05/2014 - 06/2006
2	MelanocortinsIBA 05/2014 - 12/2009
2	Antineoplastic Agents (Antineoplastics)IBA 05/2014 - 02/2006
2	Small Interfering RNA (siRNA)IBA 05/2014 - 04/2010
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 03/2014 - 02/2006
2	VimentinIBA 06/2013 - 10/2012
2	Immunosuppressive Agents (Immunosuppressants)IBA 03/2011 - 02/2006
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 01/2010 - 07/2009
2	Indicators and Reagents (Reagents)IBA 09/2007 - 10/2006
2	alpha-MSHIBA 05/2007 - 02/2006

Therapy/Procedure

18	Therapeutics 06/2021 - 02/2006
3	Drug Therapy (Chemotherapy) 10/2020 - 07/2010
3	Lasers (Laser) 01/2018 - 04/2010
2	Aftercare (After-Treatment) 01/2021 - 02/2014
2	Chemoprevention 01/2019 - 05/2009
2	Ligation 01/2018 - 01/2010